Skip to main content
Cheat SheetMidwife Licensure Exam · Midwifery Pharmacology & Newborn ProceduresReal content

Midwife Licensure Exam Midwifery Pharmacology & Newborn ProceduresMidwifery Pharmacology — The Limited FormularyCheat Sheet

A printable cheat sheet for Midwifery Pharmacology — The Limited Formulary, built for Midwife Licensure Exam reviewers who want one go-to reference in the final stretch. Covers formulas, key definitions, common question types, and the Professional Regulation Commission (PRC) — Board of Midwifery-specific twists you will see on Midwife Licensure Exam day.

Exam context

For the Midwife Licensure Examination, Professional Regulation Commission (PRC) — Board of Midwifery tests Midwifery Pharmacology & Newborn Procedures under a "Core" label, with Midwifery Pharmacology — The Limited Formulary in the 1st slot across 4 chapters. Midwife Licensure Exam candidates must clear the 75% weighted average cut on the 2026 paper, which draws about a meaningful share of Midwifery Pharmacology & Newborn Procedures questions. Date to watch: April and November 2026 (expected).

Midwifery Pharmacology — The Limited Formulary - Cheat Sheet

Your last-minute exam companion: condensed drug protocols, doses, routes, and contraindications. Master the AMTSL sequence, newborn regimens, and the critical 'refer' boundary. Every fact here is testable.

Sections

Formulas

Formula

Oxytocin AMTSL = 10 IU IM within 1 minute of baby delivery

Meaning

IU = international units; IM = intramuscular; timing is after ruling out second twin

Watch Out

NEVER give oxytocin before the baby is born (risk of uterine rupture, fetal death). NEVER use oxytocin to induce or augment labor in the first or second stage — that is physician-only.

When To Use

Immediately after the baby is born (before placenta is delivered) — the single most important action to prevent PPH

Formula

Oxytocin PPH treatment (IV infusion) = 20–40 IU in 1 litre isotonic fluid

Meaning

Given as drip while arranging urgent referral; the dose and dilution vary by setting and protocol

Watch Out

Oxytocin IV must flow over 10–40 minutes minimum (too fast = hypotension). Always have IV access secure before starting; use isotonic saline or Ringer's, not dextrose solutions.

When To Use

Active PPH with IV access; maintain while referring for high-dependency care

Common Values

Value

10 IU intramuscular

Symbol

Oxt AMTSL

Quantity

Oxytocin AMTSL dose

Value

3–5 minutes

Symbol

t onset (IM)

Quantity

Oxytocin IM onset

Value

30–60 minutes

Symbol

t duration (IM)

Quantity

Oxytocin IM duration

Value

0.2 mg IM

Symbol

Erg dose

Quantity

Ergometrine standard dose

Value

600 mcg orally

Symbol

Miso AMTSL

Quantity

Misoprostol AMTSL

Value

800 mcg

Symbol

Miso PPH

Quantity

Misoprostol PPH treatment

Section Title

AMTSL & Oxytocics — The PPH Prevention & Treatment Core

Important Facts

  • Oxytocin is the FIRST-CHOICE uterotonic because it does NOT raise blood pressure (safe even when BP status unknown).
  • Ergometrine is second-line; absolutely forbidden in hypertension/pre-eclampsia/eclampsia.
  • Misoprostol 600 mcg orally is a heat-stable alternative for AMTSL where cold chain unavailable; 800 mcg for PPH treatment (per DOH protocol).
  • PPH priority actions in order: CALL/REFER → Massage uterus → Give oxytocin → Empty bladder → Check for tears.
  • Uterine massage is done immediately after placental delivery, then every 15 minutes for the first 2 hours postpartum to maintain contraction and prevent atony.
  • Oxytocin onset is rapid (IV: <1 min; IM: 3–5 min); duration IM ~30–60 min, so IM dosing may need repeating.
  • Always rule out a second twin or retained placenta BEFORE giving oxytocin to a woman bleeding actively.
  • Oxytocin for labor induction/augmentation in first/second stage is a PHYSICIAN ONLY act — midwife's oxytocin use is confined to AMTSL and PPH (third stage onward).

Key Definitions

Term

Active Management of Third Stage Labor (AMTSL)

Example

You deliver the baby, check for a second twin, inject oxytocin IM immediately, then wait for a strong contraction before gentle cord traction while guarding the uterus.

Definition

Three-step protocol: (1) oxytocin 10 IU IM within 1 min of birth; (2) controlled cord traction with counter-traction; (3) uterine massage every 15 min × 2 hours postpartum.

Term

Postpartum Hemorrhage (PPH)

Example

A mother delivers normally but continues to bleed heavily 30 minutes postpartum; blood-soaked pads, pale, weak pulse. This is PPH — massage uterus, check for retention/tears, give oxytocin, call for help.

Definition

Loss of ≥500 mL blood within 24 hours of vaginal delivery (or ≥1000 mL after cesarean) — the #1 direct cause of maternal death in the Philippines.

Term

Ergometrine (methylergometrine)

Example

Woman with known high BP goes into labor — use oxytocin, NOT ergometrine, for AMTSL to avoid worsening hypertension.

Definition

Uterotonic alternative to oxytocin; 0.2 mg IM; CONTRAINDICATED in hypertension, pre-eclampsia, eclampsia, heart disease (causes vasoconstriction and BP rise).

Diagrams To Know

  • Three-component AMTSL sequence (oxytocin → cord traction → massage)
  • PPH decision tree: Is uterus atonic? Are there tears? Is placenta retained?
  • Timeline of oxytocin action: onset, peak, duration by route (IM vs IV)

Formulas

Formula

Vitamin K1 (phytomenadione) term = 1 mg IM

Meaning

mg = milligrams; IM = intramuscular into vastus lateralis (anterolateral thigh); for infants ≥1.5 kg at birth

Watch Out

Do NOT give IV push (risk of kernicterus and thrombosis). Do NOT delay — early administration is protective. Verify correct site (thigh, not buttock).

When To Use

Within first hour(s) after delivery to every term newborn; single dose prevents Vitamin K Deficiency Bleeding (VKDB).

Formula

Vitamin K1 preterm/LBW = 0.5 mg IM

Meaning

For newborns <1.5 kg (preterm or LBW); smaller dose due to smaller body mass

Watch Out

Do not confuse with term dose (1 mg); always check birth weight. If birth weight unknown, use 1 mg (safe) unless very clearly small/preterm.

When To Use

Preterm or low-birth-weight newborn at delivery; same timing and route as term dose

Formula

Erythromycin ophthalmic ointment eye prophylaxis = thin ribbon each lower conjunctival sac

Meaning

Concentration = 0.5%; apply to both eyes; no quantified volume because it is applied as a ribbon from tube

Watch Out

Do NOT irrigate eyes after application — the ointment must remain in contact. Apply AFTER bonding/drying to avoid washing away. Do NOT use silver nitrate (outdated; can cause irritation).

When To Use

Within the first hour after birth to prevent ophthalmia neonatorum (gonococcal/chlamydial conjunctivitis)

Common Values

Value

1 mg IM

Symbol

VitK1 term

Quantity

Vitamin K1 term infant dose

Value

0.5 mg IM

Symbol

VitK1 preterm

Quantity

Vitamin K1 preterm/LBW dose

Value

0.5% ophthalmic ointment

Symbol

Eryth oint

Quantity

Erythromycin concentration

Value

1% ophthalmic ointment

Symbol

Tetra oint

Quantity

Tetracycline alternative concentration

Section Title

Newborn Prophylaxis — Vitamin K & Eye Protection

Important Facts

  • VKDB prevention is a core newborn right under Unang Yakap/EINC protocol.
  • Vitamin K is fat-soluble; IM absorption is rapid and reliable (better than oral in resource-limited settings).
  • Erythromycin ointment is the DOH-preferred eye prophylaxis agent; tetracycline 1% is an alternative.
  • Eye prophylaxis is applied after the cord is cut, baby dried, and mother-infant bonding initiated (usually within 1 hour, but exact timing varies by facility).
  • Do NOT irrigate the eyes after ointment — this washes away the protective agent.
  • Vitamin K 1 mg term + erythromycin ointment are routine, non-negotiable newborn preventions.
  • If birth weight is very uncertain, give 1 mg (safe for all; slightly 'over-dose' for tiny baby but not harmful).
  • Vitamin K may be refrigerated (2–8 °C) but check expiry; heat-sensitive.

Key Definitions

Term

Vitamin K Deficiency Bleeding (VKDB)

Example

An unimmunized newborn presents with spontaneous GI or intracranial bleeding at 2–7 days old; preventable by routine Vitamin K prophylaxis at delivery.

Definition

Potentially fatal bleeding in the newborn caused by lack of Vitamin K-dependent clotting factors; preventable by IM phytomenadione within hours of birth.

Term

Ophthalmia Neonatorum

Example

Mother with untreated chlamydia delivers vaginally; baby develops purulent conjunctivitis within 5–14 days if not protected by erythromycin ointment.

Definition

Newborn conjunctivitis caused by gonococcus (N. gonorrhoeae) or Chlamydia trachomatis acquired during vaginal delivery; prevented by topical antibiotic/antimicrobial prophylaxis.

Term

Vastus Lateralis

Example

Vitamin K 1 mg is given IM into the outer front thigh, not the buttock or arm, to avoid damage to the sciatic nerve or other structures.

Definition

Anterolateral aspect of the mid-thigh; the recommended IM injection site for newborn vaccines and Vitamin K (away from nerves and blood vessels).

Diagrams To Know

  • Newborn prophylaxis timeline: birth → Vit K IM (first hour) → eye ointment → bonding
  • IM injection site anatomy: vastus lateralis (safe zone) vs. neurovascular structures to avoid
  • VKDB risk periods and bleeding manifestations (cephalohematoma, GI, ICH)

Formulas

Formula

Iron + folic acid (pregnancy standard) = 60 mg elemental Fe + 400 mcg (0.4 mg) folic acid, once daily

Meaning

Elemental iron = the bioavailable form (ferrous sulfate 200 mg tablet ≈ 60 mg elemental); folic acid in micrograms (mcg) or mg

Watch Out

Do NOT confuse elemental iron (60 mg) with salt weight (ferrous sulfate 200 mg) — know the conversion. Do NOT continue high-dose iron indefinitely postpartum (3 months is standard). Iron may cause constipation; advise high-fiber diet and hydration.

When To Use

Every pregnant woman, throughout pregnancy and continued for 3 months postpartum for anemia prevention and to restore postpartum iron stores.

Formula

Iron + folic acid (anemia treatment) = 60 mg elemental Fe twice daily (or per protocol)

Meaning

In frankly anemic pregnant women (Hb <7 g/dL or moderate-severe anemia), iron is doubled

Watch Out

Higher doses increase GI side effects (nausea, constipation). Counsel on spacing apart from tea/coffee and calcium (inhibit absorption). Expect delayed response (slow rise in Hb over weeks).

When To Use

Diagnosed anemia in pregnancy; midwife may follow facility/DOH protocol for intensified dosing

Formula

Postpartum Vitamin A (where DOH policy permits) = 200,000 IU single dose

Meaning

IU = international units; given within first weeks postpartum (exact timing per protocol)

Watch Out

HIGH-DOSE Vitamin A (≥10,000 IU/day or single doses >200,000 IU) is TERATOGENIC and ABSOLUTELY CONTRAINDICATED IN PREGNANCY. Never give high-dose Vit A to pregnant women. Only postpartum dosing is safe.

When To Use

Postpartum supplementation in settings with Vitamin A deficiency risk; part of some DOH/MNCHN protocols.

Common Values

Value

60 mg Fe + 400 mcg folic acid, once daily

Symbol

Fe/FA std

Quantity

Standard iron + folic acid (pregnancy)

Value

60 mg Fe twice daily

Symbol

Fe intensified

Quantity

Intensified iron (frank anemia)

Value

3 months postpartum

Symbol

Fe duration PP

Quantity

Duration of postpartum iron

Value

200,000 IU single dose

Symbol

VitA PP

Quantity

Postpartum Vitamin A dose

Value

<11 g/dL

Symbol

Hb anemia

Quantity

Anemia Hb threshold (1st/3rd trimester)

Section Title

Maternal Micronutrients — Iron, Folic Acid, Vitamin A

Important Facts

  • Iron supplementation in pregnancy reduces anemia risk and postpartum hemorrhage complications.
  • Folic acid prevents neural tube defects (NTDs); ideally started 3 months before pregnancy, but at least from first ANC visit.
  • Iron absorption is enhanced by vitamin C (citrus, tomatoes) and inhibited by tea, coffee, and dairy (counsel mothers on timing).
  • Constipation and dark stool are normal with iron — reassure mothers; laxative use may be needed.
  • Ferrous (Fe2+) forms are better absorbed than ferric (Fe3+); ferrous sulfate is standard.
  • Postpartum iron supplementation for 3 months restores depleted stores after pregnancy blood loss.
  • High-dose Vitamin A in pregnancy (>200,000 IU) is teratogenic; only postpartum dosing is permitted.
  • Midwife role: dispense iron + folic acid routinely, counsel on adherence and side effects, monitor for severe anemia (refer if Hb <7 or signs of cardiac strain).

Key Definitions

Term

Elemental Iron

Example

A mother is told to take 'ferrous sulfate 200 mg daily' — this provides 60 mg of actual usable iron, not 200 mg.

Definition

The bioavailable form of iron (Fe) in a supplement; ferrous sulfate 200 mg tablet contains approximately 60 mg elemental iron.

Term

Folic Acid

Example

Every pregnant woman should receive folic acid from the start of pregnancy to prevent cleft palate and spina bifida in the fetus.

Definition

Water-soluble B vitamin; essential for DNA synthesis and prevention of neural tube defects; 400 mcg standard prophylactic dose in pregnancy.

Term

Pregnancy Anemia

Example

A mother with Hb 8 g/dL is frankly anemic; iron dose is increased to twice daily until Hb rises to safe level (target ≥11 g/dL before delivery).

Definition

Hemoglobin <11 g/dL in the first/third trimester or <10.5 g/dL in the second trimester; iron deficiency is the most common cause in low-resource settings.

Diagrams To Know

  • Iron absorption pathway: factors that enhance (vitamin C) vs. inhibit (tea, phytates)
  • Timeline of folic acid supplementation: preconception → pregnancy → postpartum
  • Anemia severity grades and when to refer (Hb thresholds)

Formulas

Formula

Td (Tetanus-Diphtheria) vaccine = 0.5 mL IM per dose

Meaning

mL = millilitre; IM into deltoid (arm); each dose is 0.5 mL regardless of age/weight

Watch Out

Do NOT give more than 0.5 mL per injection. DO space doses according to minimum intervals (4 weeks minimum between TT1–TT2, 6 months minimum TT2–TT3, 1 year TT3–TT4, 1 year TT4–TT5). Do NOT count a dose given less than the minimum interval after the previous dose.

When To Use

Pregnant women (especially first contact/ANC visit); follows TT1–TT5 schedule for full protection and neonatal tetanus prevention.

Common Values

Value

0.5 mL IM

Symbol

Td/inj

Quantity

Td dose per injection

Value

4 weeks

Symbol

TT1→TT2

Quantity

Minimum interval TT1 to TT2

Value

6 months

Symbol

TT2→TT3

Quantity

Minimum interval TT2 to TT3

Value

1 year

Symbol

TT3→TT4

Quantity

Minimum interval TT3 to TT4

Value

1 year

Symbol

TT4→TT5

Quantity

Minimum interval TT4 to TT5

Value

~3 years

Symbol

Prot TT2

Quantity

Protection after TT2

Value

Lifetime

Symbol

Prot TT5

Quantity

Protection after TT5

Section Title

Immunization in Pregnancy — Tetanus/Td & Schedule

Important Facts

  • Every pregnant woman should receive Td as part of ANC; it is one of the core MNCHN interventions.
  • TT1–TT5 schedule is rigid: TT1 (as soon as possible), TT2 (≥4 weeks after TT1), TT3 (≥6 months after TT2), TT4 (≥1 year after TT3), TT5 (≥1 year after TT4).
  • A woman with TT5 completion is fully protected for all remaining reproductive years (lifetime protection).
  • TT5 completion also protects the newborn (passive transfer of maternal antibodies); neonatal tetanus is rare in fully immunized mothers.
  • Doses must be administered IM into the deltoid (arm), not the gluteus; injection into the deltoid is preferred for vaccine efficacy.
  • Mild local reaction (pain, redness at injection site) is normal and not a contraindication to future doses.
  • Severe allergic reaction is rare but manage with adrenaline; mild fever post-vaccine is not a contraindication.
  • Midwife role: administer Td per schedule, document every dose in FHSIS registers, counsel on protective timeline, refer for facility birth if TT coverage is <TT2.

Key Definitions

Term

Tetanus Toxoid (TT) / Tetanus-Diphtheria (Td)

Example

A 20-year-old primigravida books ANC at 8 weeks gestation with no prior tetanus vaccination history; she receives Td1 immediately, Td2 at 4 weeks, Td3 at 6 months, Td4 at 1 year (all during pregnancy or early postnatal period), and Td5 one year later to complete full protection.

Definition

Inactivated vaccine against tetanus and diphtheria; administered IM to pregnant women in a 5-dose series to achieve lifelong protection and prevent maternal and neonatal tetanus (MNT).

Term

Maternal and Neonatal Tetanus (MNT)

Example

A newborn with no clean delivery care and unimmunized mother develops classic neonatal tetanus (trismus, opisthotonus) at day 3–5 — 100% preventable by maternal Td5 completion.

Definition

Potentially fatal infection in mother or newborn caused by spore-forming bacterium Clostridium tetani; prevents by full (TT5) maternal immunization.

Term

Protective Immunity (TT schedule)

Example

A woman who received only TT1 has zero protection; after TT2 (4 weeks later), she has 3-year protection, adequate for her first pregnancy; after TT5, she is protected for all future pregnancies.

Definition

Level of antibodies sufficient to prevent disease; each TT dose confers progressively longer-lasting protection: TT2 ~3 years, TT3 ~5 years, TT4 ~10 years, TT5 ~lifetime.

Diagrams To Know

  • TT1–TT5 dosing timeline with minimum intervals and protective periods
  • Protective immunity level at each dose (TT2 = ~3 yr, TT3 = ~5 yr, TT4 = ~10 yr, TT5 = lifetime)
  • Decision tree: Is mother protected for this pregnancy? (Check TT dose history and dates)

Formulas

Formula

DMPA (Depot Medroxyprogesterone Acetate) = 150 mg IM every 3 months

Meaning

mg = milligrams; IM intramuscular; given once every 12 weeks (84 days) for contraceptive coverage

Watch Out

Injection site must be alternated (left and right buttock, or left and right deltoid per protocol) to avoid local adverse effects. If >12 weeks overdue, pregnancy must be ruled out before re-injection. Weight gain is common side effect; counsel proactively. Return-to-fertility may be delayed after last injection (up to 12 months).

When To Use

Highly effective long-acting reversible contraception; preferred in lactating women (does not impair milk supply, unlike combined oral contraceptives).

Common Values

Value

150 mg IM every 3 months

Symbol

DMPA dose

Quantity

DMPA standard dose

Value

84 days (12 weeks)

Symbol

DMPA interval

Quantity

DMPA interval (days)

Value

Day 1 of menses (immediate protection) or day 2–5 (backup x7 days)

Symbol

COC start

Quantity

COC starting day

Value

28 pills (no pill-free interval)

Symbol

POP pack

Quantity

POP pill count (pack)

Value

6 months postpartum (exclusive breastfeeding)

Symbol

LAM duration

Quantity

LAM duration

Section Title

Family Planning Contraceptives — Pills, Injectables, Barriers

Important Facts

  • COCs are contraindicated in smokers >35 years (increased cardiovascular risk), uncontrolled hypertension (SBP >160 or DBP >100), and history of VTE/stroke.
  • POPs and DMPA are preferred in breastfeeding women (do not suppress lactation like estrogen does).
  • COCs should ideally be started on day 1 of menses (immediate protection); if started after day 5, backup contraception (condoms) needed for 7 days.
  • DMPA is highly effective (>99% if given on schedule) and convenient (every 3 months); injection can be IM deltoid or buttock per protocol.
  • Condoms provide dual protection (pregnancy + STI prevention) and are suitable for all women; no medical contraindications.
  • IUD and implants require specialist insertion and are not administered by midwives in primary care; midwife refers to trained provider (though she may counsel and support user).
  • Side effects must be counseled: COC (nausea, slight weight gain, breast tenderness), DMPA (weight gain, delayed return to fertility), POP (irregular bleeding).
  • Midwife screens for contraindications at every FP visit: BP, smoking history, VTE/stroke history, current medications, breastfeeding status.

Key Definitions

Term

Combined Oral Contraceptive (COC)

Example

A non-breastfeeding woman starts a 28-day COC pack on the first day of menses; she takes one pill daily for the first 21 days, then follows the placebo week (withdrawal bleed occurs) before starting the next pack.

Definition

Pill containing both estrogen and progestin; taken daily for 21 days, then 7-day pill-free interval (or 28-day pack with placebo pills); typical contraceptive efficacy ~91%.

Term

Progestin-Only Pill (POP) / Minipill

Example

A lactating woman is given POP (e.g., norethisterone 0.35 mg) to take daily starting day 1 postpartum; it provides contraception without affecting milk supply (unlike COC).

Definition

Pill containing progestin alone (no estrogen); taken daily without a pill-free interval; mechanism is primarily cervical mucus thickening; preferred in breastfeeding women (does not suppress milk).

Term

Breastfeeding Amenorrhea Method (LAM)

Example

A mother exclusively breastfeeds her newborn 8+ times daily; she is protected by LAM for the first 6 months postpartum without additional contraception, but must transition to POP or DMPA if she wishes to continue breastfeeding beyond 6 months while preventing pregnancy.

Definition

Natural contraceptive effect of exclusive breastfeeding; provides ~98% protection if fully exclusive, frequent (8+ feeds/day), and within 6 months postpartum; requires counseling on when to add backup method.

Term

Relative Contraindication (for COC)

Example

A 38-year-old smoker requests COC; this is a relative contraindication (increased VTE/stroke risk); midwife counsels risks and offers alternatives (POP, DMPA, condom) as preferable options.

Definition

Condition that warrants caution but does not absolutely forbid use (e.g., age >35 with smoking, controlled hypertension); risk-benefit is assessed case-by-case by provider.

Term

Absolute Contraindication (for COC)

Example

A woman with a history of deep vein thrombosis (DVT) must NOT receive COC; midwife offers POP, DMPA, or condom instead.

Definition

Condition that forbids use of the drug due to unacceptable risk; examples: uncontrolled hypertension, history of thromboembolism, active breast cancer.

Diagrams To Know

  • Decision tree: Breastfeeding yes/no? → COC vs. POP vs. DMPA vs. condom
  • COC pack structure: 21 active pills + 7-day pill-free interval (or 28-pack with placebos)
  • DMPA injection timeline: every 12 weeks (84 days), alternate injection site

Formulas

Formula

MgSO₄ Loading IV = 4 g (20% solution) slow IV over 5–20 minutes

Meaning

g = grams; IV = intravenous; 20% = 20 g in 100 mL solution; dilute in normal saline or give undiluted per protocol; must infuse SLOWLY (not IV push)

Watch Out

NEVER give IV push (risk of hypermagnesemia, cardiac arrhythmia, respiratory arrest). ALWAYS check for safety signs (RR ≥12, urine ≥30 mL/hr, patellar reflex present) BEFORE each dose. Infuse slowly over at least 5 minutes; 20 minutes is safer.

When To Use

First-aid emergency measure for severe pre-eclampsia or eclampsia; given before and during referral to a facility capable of high-dependency care.

Formula

MgSO₄ Loading IM = 5 g (50% solution) deep IM into each buttock (10 g total) + 1 mL 2% lignocaine per injection

Meaning

g = grams; IM = intramuscular (deep, into gluteus maximus); 50% = 50 g per 100 mL; lignocaine is added to reduce pain; this is given concurrently with IV dose

Watch Out

MUST be deep IM (not subcutaneous). Alternate buttocks for the two injections (left and right). Lignocaine reduces local pain and can be mixed into the syringe before injection. Risk of abscess if technique is poor; use sterile needle and aseptic technique.

When To Use

Part of the complete loading regimen (given at the same time as IV dose, not after) to achieve rapid therapeutic MgSO₄ levels for seizure prevention.

Common Values

Value

4 g (20% solution) over 5–20 minutes

Symbol

MgSO4 IV load

Quantity

MgSO₄ loading IV dose

Value

10 g (5 g × 2 buttocks, 50% solution) with 1 mL 2% lignocaine each

Symbol

MgSO4 IM load

Quantity

MgSO₄ loading IM total

Value

1 g (10 mL of 10% solution) slow IV

Symbol

Ca glu antidote

Quantity

Calcium gluconate antidote dose

Value

≥12–16 breaths/minute

Symbol

RR safe

Quantity

Safety threshold: Respiratory rate

Value

≥30 mL/hour (≥100 mL/4 hours)

Symbol

UO safe

Quantity

Safety threshold: Urine output

Value

Present (brisk)

Symbol

Reflex safe

Quantity

Safety threshold: Patellar reflex

Section Title

Magnesium Sulfate — Eclampsia Loading Dose & Emergency Anticonvulsant

Important Facts

  • MgSO₄ is the ONLY emergency anticonvulsant administered by midwives; phenytoin and other anti-epileptics are physician drugs.
  • Loading dose (IV 4 g + IM 10 g) is given as a complete package, not sequentially — IV and IM injections are given at the same time or within minutes.
  • Maintenance dose (5 g IM every 4 hours in alternate buttocks for 24 hours postpartum or per facility protocol) is a PHYSICIAN/FACILITY responsibility; midwife role is loading dose only.
  • Three safety checks MANDATORY before and between every MgSO₄ dose: (1) Respiratory rate ≥12–16 breaths/min; (2) Urine output ≥30 mL/hr (or ≥100 mL in 4 hours); (3) Patellar reflex present (not diminished/absent).
  • If ANY safety sign is abnormal, STOP MgSO₄ and check for toxicity; if reflexes lost or RR <12, give antidote calcium gluconate 1 g (10 mL of 10% solution) slow IV.
  • Calcium gluconate 1 g IV is the ANTIDOTE to MgSO₄ toxicity; keep it available at the bedside whenever giving MgSO₄.
  • MgSO₄ has neuroprotective and seizure-preventive effects; it reduces the risk of eclampsia by ~50% in pre-eclampsia.
  • Midwife gives loading dose before referral; the mother travels with a companion who continues monitoring (RR, reflex, urine output) during transport.

Key Definitions

Term

Severe Pre-Eclampsia

Example

A woman at 32 weeks is found to have BP 165/115, proteinuria 3+, and severe headache unrelieved by paracetamol; this is severe pre-eclampsia — give MgSO₄ loading and refer urgently.

Definition

Hypertension (SBP ≥160 or DBP ≥110 mmHg) + proteinuria (≥2+ on dipstick or ≥300 mg/L) + at least ONE of: headache, visual disturbance, epigastric pain, seizure/eclampsia, pulmonary edema, oliguria, fetal distress.

Term

Eclampsia

Example

A woman in labor suddenly develops a generalized tonic-clonic seizure (previously had HTN and proteinuria); this is eclampsia — give MgSO₄ loading immediately, protect airway, and refer emergently.

Definition

Hypertension + proteinuria + generalized seizure(s) occurring during pregnancy/labor/postpartum; a medical emergency that can recur; requires MgSO₄ and urgent referral.

Term

Hypermagnesemia / MgSO₄ Toxicity

Example

After giving MgSO₄, the woman's respiratory rate falls to 10 breaths/minute and her patellar reflex is absent — these are signs of toxicity; stop MgSO₄ immediately and give calcium gluconate 1 g IV.

Definition

Overdose of magnesium causing loss of reflexes, respiratory depression (RR <12), oliguria, weakness, and potentially cardiac dysrhythmia and arrest; reversed by calcium gluconate.

Term

Patellar Reflex (Knee-Jerk Reflex)

Example

Before each MgSO₄ dose, tap the woman's patellar tendon with a small hammer; a brisk response means magnesium levels are safe; loss of reflex signals toxicity.

Definition

Brisk reflex contraction of the quadriceps muscle in response to light tap on the patellar tendon; one of the three safety signs monitored during MgSO₄ therapy.

Diagrams To Know

  • MgSO₄ loading regimen: 4 g IV over 5–20 min (run-time) + 5 g IM left buttock (run-time) + 5 g IM right buttock (run-time), all at the same time
  • Safety monitoring triangle: Respiratory rate ≥12 → Urine ≥30 mL/hr → Patellar reflex present
  • Decision tree: Signs of severe pre-eclampsia/eclampsia detected → Give MgSO₄ loading → Refer immediately → Ongoing monitoring during transport

Reactions Or Equations

Note

Calcium gluconate 1 g (10 mL of 10% solution) slow IV reverses magnesium toxicity within minutes; an antidote, not a sustained treatment.

Equation

MgSO₄ toxicity reversal: MgSO₄ + Calcium Gluconate → normalization of Mg effects

Conditions

Toxicity is defined by loss of patellar reflex OR respiratory rate <12 OR oliguria; calcium is given if these occur

Section Title

Prohibited & Referral Drugs — What the Midwife MAY NOT Give

Important Facts

  • ANTIBIOTICS: Midwife may give ONE pre-referral dose of a broad-spectrum antibiotic (e.g., ceftriaxone) for severe infection/sepsis, then MUST refer for ongoing treatment (not the midwife's role).
  • OXYTOCIN MISUSE: Using oxytocin to induce or augment labor in the first or second stage is STRICTLY FORBIDDEN (risk of uterine rupture, fetal death). Oxytocin is ONLY for AMTSL and PPH (third stage onward).
  • ANESTHESIA: General, regional, spinal anesthesia and controlled/narcotic analgesics are PHYSICIAN ONLY (never by midwife).
  • ANTI-HYPERTENSIVES: Drugs to treat hypertension (nifedipine, methyldopa, hydralazine) are PHYSICIAN acts; midwife role is detection and referral. MgSO₄ is not an anti-hypertensive; it is for seizure prevention in pre-eclampsia.
  • INSULIN & DIABETES DRUGS: Management of gestational/pre-existing diabetes is physician/endocrinologist; midwife refers and supports adherence but does not prescribe.
  • ANTICOAGULANTS: Heparin, warfarin, DOACs are PHYSICIAN drugs; midwife does not manage thromboembolism.
  • CORTICOSTEROIDS: Antenatal corticosteroids (betamethasone for fetal lung maturation <34 weeks) require physician authorization and facility-based administration.
  • ERGOMETRINE: Absolutely contraindicated in hypertension/pre-eclampsia; if BP is unknown or elevated, use oxytocin instead (safer).
  • INSTRUMENTAL/OPERATIVE ACTS: Forceps, vacuum, cesarean section, episiotomy repair, and all drugs accompanying them are PHYSICIAN/SPECIALIST acts.
  • DEFAULT RULE: If the drug 'treats a disease' or 'manages a complication' rather than 'supporting normal birth' or 'preventing a defined deficiency,' the answer is REFER.

Key Definitions

Term

Limited Formulary (RA 7392)

Example

A midwife can give oxytocin for AMTSL but cannot prescribe antibiotics for ongoing infection treatment (refer to physician). She can give Vitamin K to the newborn but cannot give insulin to a diabetic mother (refer).

Definition

Under Philippine Midwifery Act, a midwife is authorized to give a defined set of safe, life-saving drugs for NORMAL birth and prevention; all other drugs require physician prescription and referral.

Term

First-Aid / Pre-Referral Drug

Example

A mother shows signs of severe infection (fever, purulent lochia, tachycardia); midwife gives one IV dose of ceftriaxone 1 g as emergency stabilization, then immediately arranges transport to a facility where the physician will continue antibiotic therapy.

Definition

A single emergency dose of a drug (e.g., first IV dose of antibiotics, first dose of MgSO₄) given by the midwife to stabilize the mother during the critical period before referral; not a substitute for definitive care.

Diagrams To Know

  • Decision tree: Is this within the midwife's normal formulary? (Yes → give; No → refer)
  • Spectrum of care: Midwife gives (AMTSL, Vit K, eye care, iron, vaccines) vs. Physician manages (complications, disease treatment)

Must Remember

Item

OXYTOCIN 10 IU IM within 1 minute of baby delivery (after ruling out second twin) — cornerstone of AMTSL; prevents PPH, the #1 direct maternal killer in the Philippines.

Rank

1

Item

NEVER use oxytocin to induce or augment labor in first/second stage — it is ONLY for AMTSL/PPH (third stage onward). Using it for labor acceleration causes uterine rupture and fetal death.

Rank

2

Item

ERGOMETRINE 0.2 mg IM is CONTRAINDICATED in hypertension, pre-eclampsia, eclampsia, and heart disease (causes vasoconstriction and BP rise) — use OXYTOCIN instead (BP-neutral, safer).

Rank

3

Item

VITAMIN K1: 1 mg IM term infant (≥1.5 kg) or 0.5 mg preterm/LBW (<1.5 kg), single dose, vastus lateralis, within first hour(s) — prevents Vitamin K Deficiency Bleeding (VKDB).

Rank

4

Item

EYE PROPHYLAXIS: Erythromycin 0.5% ointment thin ribbon in each lower conjunctival sac within first hour (after bonding/drying) — prevents ophthalmia neonatorum; do NOT irrigate afterward.

Rank

5

Item

IRON + FOLIC ACID: 60 mg elemental Fe + 400 mcg (0.4 mg) folic acid once daily throughout pregnancy, continued 3 months postpartum — anemia prevention and treatment (double dose if frank anemia, per protocol).

Rank

6

Item

HIGH-DOSE VITAMIN A (>200,000 IU) is TERATOGENIC and ABSOLUTELY CONTRAINDICATED IN PREGNANCY — only safe postpartum (200,000 IU single dose, where policy permits).

Rank

7

Item

TD/TETANUS SCHEDULE: TT1–TT5 (0.5 mL IM each). TT2 protects ~3 years, TT5 lifetime. Minimum intervals: 4 weeks (TT1→2), 6 months (TT2→3), 1 year (TT3→4), 1 year (TT4→5). Every dose must be documented.

Rank

8

Item

DMPA (DEPO-PROVERA) 150 mg IM every 3 months (84 days); preferred in breastfeeding women (POPs are also suitable). DOES NOT suppress lactation. Alternate injection site (left/right buttock).

Rank

9

Item

MAGNESIUM SULFATE LOADING for severe pre-eclampsia/eclampsia: 4 g IV over 5–20 min + 10 g IM (5 g each buttock with 1 mL 2% lignocaine) given together, then REFER. Check three safety signs before each dose: RR ≥12, UO ≥30 mL/hr, patellar reflex present. Antidote: calcium gluconate 1 g IV if toxicity.

Rank

10

Last Minute Tips

Tip

OXYTOCIN TIMING: It must be given WITHIN 1 MINUTE of the baby being born (after excluding second twin) — delays increase PPH risk. After the cord is cut is too late; after placenta is delivered is too late. 'Within 1 minute of delivery of the baby' is the exact wording.

Tip Number

1

Tip

If an exam question asks 'What is the safest uterotonic when BP is unknown/elevated?' the answer is OXYTOCIN (not ergometrine), because oxytocin does NOT raise BP. This is asked repeatedly.

Tip Number

2

Tip

VITAMIN K & EYES are ROUTINE newborn preventions given at every vaginal delivery — if the question mentions 'normal vaginal delivery' and does not specify the newborn received these, the midwife MUST give them. They are non-negotiable.

Tip Number

3

Tip

MgSO₄ SAFETY SIGNS are tested as a 'pick all that apply' or fill-in-the-blank: RR ≥12 (not <12), UO ≥30 mL/hr, patellar reflex PRESENT. If ANY of these is abnormal, STOP MgSO₄ and give calcium gluconate. Memorize this triplet cold.

Tip Number

4

Tip

When a question says 'the midwife may NOT give' or 'this is outside the midwife's scope,' the correct answer is almost always 'refer' for anything that manages disease/complication (antibiotics for infection, insulin for diabetes, antihypertensives, anesthesia). The midwife's formulary is for NORMAL birth + prevention, not disease management.

Tip Number

5

Comparison Tables

Rows

Values

  • Uterine smooth muscle contraction
  • Vasoconstriction + uterine contraction
  • Receptor agonist; uterine contraction

Property

Mechanism

Values

  • 10 IU IM
  • 0.2 mg IM (second-line)
  • 600 mcg orally

Property

AMTSL dose

Values

  • 3–5 minutes
  • 5–7 minutes
  • 10–15 minutes

Property

Onset (IM)

Values

  • 30–60 minutes
  • 45 min–3 hours
  • 30–60 minutes

Property

Duration (IM)

Values

  • No rise (safe)
  • Raises BP (contraindicated if HTN)
  • No significant rise

Property

Effect on BP

Values

  • None (universal first choice)
  • Hypertension, pre-eclampsia, eclampsia, heart disease
  • Severe asthma (rare)

Property

Contraindication

Values

  • Effective, rapid, safe, first-line
  • Longer duration (useful if recurrent bleeding)
  • Heat-stable (no cold chain needed)

Property

Advantage

Values

  • Yes; 10 IU IM repeated, or IV infusion
  • Yes; 0.2 mg IM if oxytocin insufficient
  • 800 mcg (per DOH protocol)

Property

Use in PPH

Columns

  • Feature
  • Oxytocin
  • Ergometrine
  • Misoprostol

Table Title

Oxytocics: Oxytocin vs. Ergometrine vs. Misoprostol

Rows

Values

  • 1 mg IM
  • 0.5 mg IM

Property

Dose

Values

  • IM (intramuscular)
  • IM (intramuscular)

Property

Route

Values

  • Vastus lateralis (anterolateral thigh)
  • Vastus lateralis (anterolateral thigh)

Property

Site

Values

  • Within first hour(s) after birth
  • Within first hour(s) after birth

Property

Timing

Values

  • Single dose
  • Single dose

Property

Number of doses

Values

  • No repeat; once per lifetime
  • No repeat; once per lifetime

Property

Frequency of repeat

Columns

  • Parameter
  • Term Infant (≥1.5 kg)
  • Preterm/LBW (<1.5 kg)

Table Title

Newborn Vitamin K: Term vs. Preterm/LBW

Rows

Values

  • 0.5%
  • Thin ribbon each lower conjunctiva
  • DOH preferred; effective against N. gonorrhoeae and C. trachomatis
  • Do NOT irrigate after application

Property

Erythromycin ointment

Values

  • 1%
  • Thin ribbon each lower conjunctiva
  • Alternative to erythromycin; broader spectrum
  • Less commonly used than erythromycin

Property

Tetracycline ointment

Values

  • 1%
  • 1 drop each eye
  • Historical agent; very effective
  • Largely replaced; can irritate eyes; requires careful dosing

Property

Silver nitrate

Columns

  • Agent
  • Concentration
  • Application
  • Advantage
  • Note

Table Title

Eye Prophylaxis Agents

Rows

Values

  • 60 mg elemental Fe + 400 mcg folic acid once daily
  • Throughout pregnancy
  • Anemia prevention; maintain fetal oxygen supply

Property

Pregnancy (standard)

Values

  • 60 mg Fe twice daily (or per protocol)
  • Until Hb rises to safe level
  • Rapid correction of low Hb (Hb <7); reduce transfusion risk

Property

Pregnancy (frank anemia)

Values

  • 60 mg elemental Fe + folic acid once daily
  • 3 months postpartum
  • Restore iron stores depleted by pregnancy/labor blood loss

Property

Postpartum

Columns

  • Phase
  • Dose
  • Duration
  • Purpose

Table Title

Iron Supplementation: Pregnancy vs. Postpartum

Rows

Values

  • As soon as possible (first ANC visit)
  • No protection (0 years)
  • Not yet protective

Property

TT1 (First dose)

Values

  • ≥4 weeks after TT1
  • At least 4 weeks
  • ~3 years
  • Protective for first pregnancy

Property

TT2 (Second dose)

Values

  • ≥6 months after TT2
  • At least 6 months
  • ~5 years
  • Protective for first 2–3 pregnancies

Property

TT3 (Third dose)

Values

  • ≥1 year after TT3
  • At least 1 year
  • ~10 years
  • Extended protection

Property

TT4 (Fourth dose)

Values

  • ≥1 year after TT4
  • At least 1 year
  • Lifetime
  • Full lifelong protection

Property

TT5 (Fifth dose)

Columns

  • Dose
  • Minimum Interval from Previous Dose
  • Duration of Protection
  • Protective Level

Table Title

Td/Tetanus Vaccination Schedule (TT1–TT5)

Rows

Values

  • NO (avoid if possible)
  • Estrogen may reduce milk supply
  • Not ideal in exclusive breastfeeding; may introduce formula prematurely

Property

Combined Oral Contraceptive (COC)

Values

  • YES (preferred)
  • Progestin alone does NOT suppress lactation
  • Can start day 1 postpartum; no impact on milk

Property

Progestin-Only Pill (POP)

Values

  • YES (highly preferred)
  • Progestin alone; does NOT suppress lactation
  • Can give 6 weeks postpartum; every 3 months thereafter

Property

DMPA (Depo-Provera)

Values

  • YES (always suitable)
  • Barrier method; no hormonal effect
  • Can use from day 1; dual protection (pregnancy + STI)

Property

Condoms

Values

  • YES (natural method)
  • Exclusive breastfeeding provides natural contraception
  • Only for first 6 months AND if exclusively breastfeeding; after 6 mo. or if partial feeding, add backup method

Property

Breastfeeding Amenorrhea Method (LAM)

Columns

  • Method
  • Breastfeeding Suitable?
  • Rationale
  • Timing

Table Title

Contraceptive Methods: Suitability in Breastfeeding

Rows

Values

  • ≥12–16 breaths/minute
  • RR <12 (respiratory depression)
  • STOP MgSO₄; give calcium gluconate 1 g IV; monitor closely

Property

Respiratory Rate (RR)

Values

  • ≥30 mL/hour (≥100 mL/4 hours)
  • UO <30 mL/hr (oliguria/acute kidney injury)
  • STOP MgSO₄; check Foley catheter patency; monitor electrolytes; consider toxicity

Property

Urine Output (UO)

Values

  • Present and brisk
  • Absent or diminished (loss of reflexes)
  • STOP MgSO₄ immediately; give calcium gluconate 1 g IV slow; this is a sign of severe toxicity

Property

Patellar Reflex

Columns

  • Safety Parameter
  • Safe Threshold
  • Dangerous Finding
  • Action if Dangerous

Table Title

MgSO₄ Safety Monitoring: The Three Safety Checks

Loading diagram…
Loading diagram…
Loading diagram…
Loading diagram…
Loading diagram…

Ready to practise for the Midwife Licensure Exam 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target Midwife Licensure Exam exam date.